Michael Guerrera

Physician
Department of Pediatrics, Children’s National Hospital, Washington, USA
Washington DC, District of Columbia, United States

Presentation(s):

• PB0649 - Results From the RESIST Study for Tolerance Induction in Patients With Poor Prognosis for ITI Success

  Monday, June 26, 2023
  18:30 – 19:30 ET